Final Project
Final Project
Final Project
1.1 BACKGROUND
HIV infection has spread over the last 30 years and has a great impact on
health, welfare, employment and criminal justice sectors; affecting all social
and ethnic groups throughout the world. Recent epidemiological data indicate
that HIV remains a public health issue that persistently drains our economic
sector having claimed more than 25 million lives over the last three decades 2.
1
and an estimated 1.9 million people living with HIV, is one of the high burden
countries 4.
Health infrastructure is an intricate support for public health delivery and the
nerve centre of public health system essential in encouraging good health
services and well-being 6. It offers the basis for planning, evaluating,
delivering, and enhancing development in public health 6. As such, the
delivery of public health service in every country is hinged on its health
infrastructure 7. In Nigeria, health infrastructure is at its low ebb, as there is
huge infrastructural deficit which constitute a major challenge to public health
in Nigeria 8. In Nigeria, the Federal, State and Local government is
empowered to legislate on matters on health, considering that it is contained
in the concurrent legislative list [Second Schedule and Fourth Schedule of the
Constitution of the Federal Republic of Nigeria, 1999 (Third Alteration).]. As
such, diverse challenges facing health care sector can be analyzed from
different levels of health care thus: Tertiary health care (managed by the
Federal Government), secondary health care (managed by the State
Government) and primary health care (administered by Local Government) 9.
Interestingly, a common challenge of these three triers of health care is the
deficiency in healthcare infrastructure. Most health institutions battle with age
long problem of weak, defective, insufficient and obsolete infrastructure 10.
2
patient or healthcare providers and for the purpose of improving patient care
12
.
3
1.1.4 TELECONSULTATION AND HIV CARE
In 2020, an estimated 87% of people living in LMICs (Low and Middle Income
Countries) had access to a mobile phone, and over half of those in LMICs
used the Internet 12. Although Telemedicine has long been technologically
feasible, it was not widely adopted until the coronavirus disease 2019
(COVID-19) pandemic necessitated remote health care delivery options that
supported physical-distancing precautions, Implementing telemedicine
services during COVID-19: guiding principles and considerations for a
stepwise approach 19. After widespread uptake during the pandemic,
Telemedicine has the potential to address existing and growing inequities in
the global HIV response by improving both provider-patient and provider-
provider communication 20.
While Telemedicine holds promise for the prevention and management of HIV
and other chronic diseases in LMICs, there are several challenges to consider
before widespread implementation can be realised 21. At the national level,
countries may lack sufficient legal and regulatory frameworks to guide
telemedicine implementation 22. Regulations such as those governing
licensure, online prescribing, and financial reimbursement mechanisms may
need to be developed or modified 23. A 2015 WHO evaluation found that only
22% of the 125 countries surveyed had a national policy for Telemedicine 24. A
lack of national strategy for Telemedicine can lead to gaps in coordination
among stakeholders, particularly between the private and public sectors.
Many pilot programs in LMICs have been funded by private donors and run
without the involvement of local governments 25.
4
has introduced telehealth specific services to people living with HIV (PLHIV) in
the state.
SandsClinic is a fast growing telemedicine company with the aim of providing
convenient and affordable healthcare that saves customers time so that they
can face family and other things.27
5
improving healthcare access and delivery, there is a lack of comprehensive
research on the awareness and acceptability of these technologies
specifically among patients living with HIV attending a tertiary center in
Nigeria. This research aims to address this gap by examining the following
key aspects:
6
cases. Tertiary centers serve as important hubs for HIV/AIDS care, providing
specialized treatment and management. However, challenges such as long
distances to healthcare facilities, limited healthcare resources, and stigma
associated with the disease can impede patient access to quality care. By
investigating the awareness and acceptability of telemedicine and tele-
consultation among patients living with HIV in a tertiary center, this study aims
to identify the potential benefits and barriers that telemedicine can offer to
improve healthcare access and outcomes for this vulnerable population.
The insights gained from this study can inform policymakers, healthcare
providers, and stakeholders in Nigeria's healthcare system. Understanding the
barriers and facilitators to the adoption of telemedicine can help shape
healthcare policies that promote the integration of telemedicine services into
existing HIV/AIDS care programs. Additionally, healthcare providers can use
the findings to develop targeted interventions and educational programs to
raise awareness and promote the acceptability of telemedicine among
patients living with HIV.
7
To achieve the stated objectives, this research will seek answers to the
following questions:
1.5 AIM/OBJECTIVES
Aim/General Objective:
Specific Objectives:
8
CHAPTER 2
Literature Review
2.1 Introduction
The advent of advanced computer and internet technologies since the early
1990s has opened novel avenues for doctors and patients. In developed
nations, doctors employ computers to transmit real-time video, audio, and
high-resolution images across vast distances, even conducting patient
assessments in clinics thousands of miles away 28. Moreover, the rapid
proliferation of mobile phones, promising universal connectivity, strengthens
the belief that the latest generation of information and communication
technologies (ICTs) will drive significant beneficial transformations in the
healthcare sector's organization 29.
Global concerns about health issues have escalated due to a surge in life-
threatening ailments, some of which remain incurable. The complex nature of
health challenges in Nigeria has necessitated multifaceted study approaches
30
.
The far-reaching impact of HIV infection over the past three decades has
reverberated across health, social, economic, and legal domains, affecting
diverse global demographics. Recent epidemiological data underscore the
ongoing public health challenge posed by HIV, which has claimed over 25
million lives. This continuing burden exerts strain on economies 31.
9
Despite substantial strides in combatting the HIV pandemic, a significant
global burden persists. In 2022 alone, 16.9 million males were living with HIV,
contributing substantially to the total of 39 million survivors of the epidemic 32.
Sub-Saharan Africa shoulders a considerable portion of this burden, housing
25.6 million people with HIV and accounting for more than half (50.8%) of all
new HIV cases worldwide. Nigeria, with an HIV prevalence of 1.4%, is among
the high burden countries, with an estimated 1.9 million individuals living with
HIV 33.
10
were 4.7 and 2.5 mmHg larger, respectively, in the BP tele-monitoring group.
Furthermore, a significantly higher proportion of patients in the intervention
group achieved office BP normalization (< 140/90 mmHg for non-diabetic and
< 130/80 mmHg for diabetic patients), demonstrating the effectiveness of the
intervention 36.
11
teleconsultation, its outcomes, patient satisfaction, and factors influencing
teleconsultation services 39.
12
demographics, CD4 trends, and adverse effects. This telemedicine platform
also facilitated the tracking and monitoring of cases lost to follow-up 43.
13
Integrating telehealth-assisted interventions into HIV/AIDS care could
contribute to continuous care and sustained well-being 46.
14
2.6 Telemedicine Implementation and readiness in resource limited
settings
15
2.7 Best practices and guidelines for teleconsultation in HIV care
People living with HIV (PWH) face an elevated risk of episodic or permanent
disability due to their condition.55 Additionally, individuals with disabilities are
more susceptible to HIV infection due to limited testing access or resources. 56
Regrettably, there is scant knowledge about telehealth utilization among
individuals with disabilities and chronic diseases, including HIV, amid the
pandemic. A US study suggests that approximately 40% of people with
disabilities may have availed themselves of telehealth during the pandemic. 57
However, utilization patterns differed based on the type of disability and
socioeconomic status. For instance, those with mobility or cognitive
disabilities were more inclined to use telehealth compared to those with
hearing or visual impairments. Moreover, individuals with disabilities
possessing graduate degrees and insurance displayed a higher likelihood of
using telehealth in comparison to other groups. 58 The findings from this US
study further underscore disparities in telehealth utilization. Consequently, it
becomes imperative to delve into the role of telehealth in managing chronic
16
diseases within this demographic, while assessing its implications on their
quality of life, healthcare access, and overall outcomes.
1.
Input Factors:
1.
Demographic Characteristics: Age, gender, education,
socioeconomic status, insurance coverage, type of disability.
2.
Healthcare Infrastructure: Availability of telehealth services,
institutional support, healthcare access.
2.
Process Factors:
17
1.
Telehealth Modalities: Video visits, telephone calls, text messaging,
web-based content, applications.
2.
Telehealth Utilization: Frequency, purpose, duration of telehealth
interactions.
3.
Patient-Provider Communication: Communication quality,
information exchange, rapport building.
3.
Mediating Factors:
1.
Disability Impact: Level of disability, episodic/permanent disability,
impact on mobility/cognition.
2.
Healthcare Access: Geographical barriers, transportation limitations,
in-person visit challenges.
3.
Health Literacy: Understanding of telehealth platforms,
communication preferences, technological proficiency.
4.
Outcome Factors:
1.
Quality of Care: Patient satisfaction, perceived effectiveness of
telehealth for chronic disease management.
2.
Healthcare Outcomes: Viral load control, CD4 count stability,
medication adherence, disease progression.
3.
Quality of Life: Emotional well-being, social connectedness,
psychological impact of disability and disease management.
4.
Health Disparities: Differential telehealth utilization, disparities in
health outcomes among subgroups.
5.
External Factors:
1.
Healthcare Policies: Telehealth regulations, reimbursement policies,
incentives for telehealth utilization.
2.
Technological Advancements: Accessibility of devices, user-friendly
platforms, continuous tech improvements.
18
3.
Sociocultural Context: Stigma, societal attitudes towards disabilities,
community support systems.
6.
Feedback Loop:
1.
Patient Preferences: Preferred telehealth modalities, communication
style, satisfaction with services.
2.
Provider Practices: Adaptation of telehealth to patient needs,
challenges faced in delivering telehealth care.
19
Summary
CHAPTER THREE
20
METHODOLOGY
The state has several tertiary hospitals, including Aminu Kano Teaching
Hospital, National Orthopaedic Hospital Dala, Murtala Muhammad Specialist
Hospital, and Muhammad Abdullahi Wase Specialist Hospital. Additionally,
secondary care hospitals and primary level care centers, such as
Comprehensive and Primary Health care Centers, are strategically dispersed
across the state.
The study will be conducted at Aminu Kano Teaching Hospital, one of the two
tertiary referral centers [Dala Orthopaedic hospital is the other one] under the
Federal Ministry of Health for over 13 million people located in Kano, in
northern Nigeria.60 The hospital operated at a temporary site at Murtala
Muhammad Specialist Hospital, Kano before moving to the permanent site
along Zaria Road in Tarauni local government in January 1996. Presently, the
hospital is easily accessible via the various tarred roads and several transport
21
systems operating in the area.
Study population
The study participants will be adults (≥18 years old) of both sexes, living with
HIV, and enrolled in the antiretroviral treatment (ART) program at AKTH. As
patients arrive for their appointments, they will be registered sequentially and
allocated to a consultation room. While waiting for their turn, a trained health
worker will inform them of the purpose of the study and request their
participation. The research assistants will check for eligibility. Only patients
who provide informed consent will be interviewed. We will exclude individuals
who are too ill to be interviewed and those with cognitive impairment.
22
from an infinite population.
n = (z2pq) /d2
Where n=the minimum sample size,
z = the percentage point of the standard normal distribution curve, which the
curve defines 95% confidence interval (the value obtained from a normal
distribution table is 1.96).
p = prevalence of acceptability of telemedicine consultation from a previous
study (41.1%) equivalent to p=0.411) Arize Ifeanyi et al.61
q = complementary probability of p i.e. (1-p = 1-0.411 = 0.589)
d = maximum sampling error tolerable (i.e. precision)=5%, equivalent to 0.05
n= [(1.96)2(0.411) (0.589)]/0.052 = 371.9=372
Based on the above, the minimum sample size was 372 but 10% of the
calculated minimum sample size was added to cater for anticipated non-
response (372/0.90) giving 414.
23
awareness and knowledge of telemedicine and tele consultations and Section
C will assess the acceptability and experiences with telemedicine and tele
consultation. Examples of questions assessing acceptability of tele-
consultation include:
Would you be willing to use tele-consultation services for your HIV care?
( ) Yes
( ) No
( ) Not Sure
To elucidate survey findings, the qualitative interview guide will have open-
ended questions with probes for detailed descriptions. The guide will explore
PLHIV’s perceptions of telemedicine, acceptability and experiences. All
participants will provide written or thumb-printed informed consent.
Confidentiality in reporting qualitative findings will be ensured by removing
identifiers.
The study protocol will be reviewed and approved by the Aminu Kano
Teaching Hospital/Bayero University Research Ethics Committees. Potential
participants will be individually contacted by trained research assistants and
provided detailed information on the study objectives and what participation
entailed. They will be informed that participation is voluntary. Those who sign
an informed consent form will be interviewed in a private room allocated for
the purpose.
24
administration of the questionnaires.
Data Analysis
The data will be entered into a Microsoft Excel spreadsheet and subsequently
analyzed using the IBM Statistical Package for the Social Sciences (SPSS)
Version 22. Prior to analysis, a thorough process of data cleaning and
checking will be conducted to eliminate incomplete, inaccurate, and
inconsistent data entries.
CHAPTER 4: RESULTS
25
Out of a total of 450 questionnaires distributed, 415 were successfully
completed and retrieved, yielding a response rate of 92%.
4.2. SOCIO-DEMOGRAPHICS
Frequency Percent
AGE <20 2 0.5
GROUP 20-29 60 14.4
30-39 139 33.5
40-49 133 32.0
>/=50 81 19.5
Total 415 100.0
26
Table 4.2 depicts the age distribution of the participants with majority of the
patients in age category of 30-49, reprensenting about 65.5% of the
respondents.
27
MARITAL SINGLE 66 15.9
STATUS MARRIED 257 61.9
DIVORCED 38 9.2
WIDOWED 54 13
28
29
30
3. CLINICAL CHARACTERISTICS
31
Table 4.5 Types of co-morbidities
Frequency Percent
CARDIAC DISEASE 1 0.2
DIABETES 6 1.4
FIBROID 2 .5
HEART FAILURE 1 .2
HYPERTENSION 37 8.9
HYPERTENSION AND DIABETES 3 0.7
ULCER 2 0.5
Total 56 13.5
Table 4.5 shows the distribution of comorbidities amongst the participants,
with hypertension taking about 37%, then followed by diabetes mellitus.
32
4.3 Level of Awareness of Telemedicine
Table 4.8
Frequency Percent
Heard of Telemedicine NO 309 74.5
before the survey? YES 106 25.5
Total 415 100.0
Table 4.9
Frequency Percent
Familiar with any NO 400 96.4
Telemedicine services YES 15 3.6
in Nigeria? Total 415 100.0
33
Table 4.10
Frequency Percent
Interested about YES 261 62.9
learning about NO 121 29.1
Telemedicine? NOT 33 8.0
SURE
Total 415 100.0
Table 4.11
Frequency Percent
How often do you use DAILY 254 61.2
technology or internet in WEEKL 57 13.7
your daily life? Y
MONTHLY 17 4.1
RARELY 57 13.7
NEVER 30 7.2
Total 415 100.0
From these tables only 25.5% heard about telemedicine before the survey
and only 3.6% are familiar with Telemedicine services in Nigeria, However
about 62.9% are interested in knowing more about it, and a significant number
of them (61.2%) use technology and internet daily.
34
4.4 Acceptability and willingness to use Teleconsultation
The acceptability and willingness of patients living with HIV to use tele-
consultation services are outlined below;
Table 4.12
Frequency Percent
Willing to use YES 231 55.7
use NO 133 32.0
Teleconsultatio NOT 51 12.3
n services for SURE
HIV care Total 415 100.0
Table 4.13
Frequency Percent
QAS NO 214 51.6
YES 201 48.4
Total 415 100.0
Table 4.14
Frequency Percent
Value VERY ACCEPTABLE 46 11.1
ACCEPTABLE 180 43.4
NEUTRAL 117 28.2
UNACCEPTABLE 71 17.1
VERY UNACCEPTABLE 1 0.2
Total 415 100.0
From these tables above it was depicted that about 55.7% are willing to use
Teleconsultation services for their HIV care and a Qualified acceptability score
of 48.4%,and also a significant crude acceptability score, where 43.4%
choses ACCEPTABLE and about 11.1% VERY ACCEPTABLE.
35
4.5 Factors Associated with Acceptance and Willingness to Use Tele-
Consultation
The factors associated with patients' acceptance and willingness to use tele-
consultation services for HIV care are presented below;
36
Respondents’ Accepatance and willingness
Socio- to use teleconsultation and
demographic Telemedicine sevices
Total
χ2 P Value
Factors
YES NO NOT
SURE
Male 101 24 19 144
Female 130 109 32 271
Ethnicity 8.049 0.429
Hausa 141 88 35 264
Fulani 44 21 8 73
Yoruba 26 10 2 38
Igbo 9 7 5 21
Others 11 7 1 19
Religion 0.161 0.923
Islam 198 116 44 358
Christianity 33 17 7 57
Marital status 38.395 <0.001
Single 45 17 4 66
Married 154 68 35 257
Divorced 17 13 8 38
Widowed 15 35 4 54
Family type
Monogamous 177 91 44 312 11.366 0.023
Polygamous 54 42 07 103
Highest level
of Education
Quran/Islamic 28 31 13 72 41.442 <0.001
Primary 9 19 3 31
Secondary 70 43 19 132
Tertiary 104 26 14 144
Others 20 14 2 36
Occupation 40.833 <0.001
Housewife 44 26 18 88
Unemployed 7 15 7 29
Trading 37 33 3 73
Farming 11 7 1 19
Civil servant 40 12 6 58
37
Respondents’ Accepatance and willingness
Socio- to use teleconsultation and
demographic Telemedicine sevices
Total
χ2 P Value
Factors
YES NO NOT
SURE
Business 64 25 14 103
Student 15 4 2 21
Others 13 11 0 24
Table 4.15
FACTOR CHI-SQUARE P-VALUE ASSOCIATION
AGE 9.412 0.309 -
GENDER 24.729 <0.001 +
ETHNICITY 8.049 0.429 -
RELIGION 0.161 0.923 -
MARITAL STATUS 38.395 <0.001 +
FAMILY TYPE 11.366 0.023 +
HIGHEST LEVEL OF 41.442 <0.001 +
EDU.
OCCUPATION 40.833 <0.001 +
INCOME 107.422 0.130 -
Table 4.15 depicts the relationship between various factors and patient's
acceptance and willingness to use teleconsultation services, with P-VALUE as
<0.005 signifying statistically significant relationship. (+) means there is
statistically significant association and (-) means ther is no statistically
significant association.
38
TREATMENT
LACK OF INFORMATION ABOUT 11 2.7
TELECONSULTATION SERVICES
OTHERS 0 0
From this table (4.16) it was noted that the main factors affecting willing to use
teleconsultation seevices are Lack of trust in technology and concerns about
privacy and security.
Also in this table (4.17) it was clearly shown that convenience and time
saving, and reduced travel cost are factors that may influence the use
teleconsultation services in HIV care.
4.6 CHALLENGES
Table 4.18
FACTOR FREQUENCY/415 PERCENTAGE
(%)
LACK OF FACE TO FACE CONSULTATION 181 43.6
TECHNICAL DIFFICULTIES 151 36.4
PRIVACY AND SECURITY CONCERNS 143 34.5
LANGUAGE BARRIERS 60 14.5
UNCERTAINTY ABOUT THE QUALITY OF 72 17.3
39
CARE
OTHERS 2 0.5
From table 4.18 it was found that the main challenges affecting the use of
teleconsultation services in HIV care are lack of face to face consultation,
technical difficulties and privacy & security concerns.
Also in the above table (4.19) it was shown that the potential benefits for using
teleconsultation services are reduced travel and transportation cost, access to
specialist care, timely medical advice and flexibilty in appointment schedule.
Qualitative findings
40
Participants expressed positive thoughts and feelings about tele-consultation,
associating it with the current economic situation and improved access to
care. The convenience of obtaining information through a simple phone call
was highlighted, as one participant stated:
"I like it; the concept is good considering the current economic situation. If you
want to contact your healthcare provider, you simply get your recharge cards
or data, call your healthcare provider, then talk and get prescribed drugs for
your care."
"To me, I feel it is very good because it shows that I am being loved and cared
for by some people somewhere. Even though there is no physical contact, at
least someone will call, 'hello, am calling from AKTH, how are you doing.'
Seriously, I will be glad."
"Well, some people think it is easier. For me, I prefer to have an in-person
consultation; it is much better than that phone call. The difference is if it is in-
person, the physician can easily assess you and see things physically, which
is not so with tele-consultation."
"The benefits are many; people don’t have to come here; it eliminates
transport costs, reduces contact with others, thereby enhancing privacy. For
the medical practitioners, they don’t have to interact with and encounter so
many people like it is now."
"There are benefits like when you are seriously ill and cannot make it down to
the clinic, or when you are too busy, then you can make a call so that you
have your medications sent to you."
41
Several circumstances might encourage individuals to opt for tele-
consultation, including factors like insecurity, lockdown situations, long
queues in clinics, emergencies at night, travel-related issues, and the
convenience of accessing healthcare remotely:
"There are so many factors; insecurity, the COVID-19 lockdown, and long
queues in the clinic. When we first started attending this clinic, we were few,
but the number of patients coming to the clinic now per day is too much for
the number of healthcare providers."
"There are challenges like network; we all know how our network signal is in
this country. Then people who cannot operate their phones very well, financial
issues of not affording the phone."
Participants outlined various factors that could influence their adoption of tele-
consultation services for HIV care. Prompt response to calls by healthcare
providers and perceived disturbance to healthcare providers were highlighted.
A participant emphasized,
"The only factor that will influence me is if I call, and they respond to me on
time, that will encourage me to be using tele-consultation anytime. But if they
don’t respond, then there is no need. Importantly, teleconsultation should be
optional; face-to-face should remain the norm."
42
While participants generally expressed comfort with tele-consultation,
concerns about phone-related issues such as low credit, network problems,
and the need for a fixed call schedule were raised. One participant stated,
"There may be concerns if I don’t have the phone or credit and also network;
then I must come to the clinic in-person for consultation."
CHAPTER 5 (DISCUSSSION)
The average age of 40, with a minimum of 18 and a maximum of 73, indicates
a diverse representation of age groups in the study. The predominance of
participants from different Local Government Areas (LGAs) illustrates the wide
geographic reach of the study, contributing to its external validity.
43
The gender distribution reveals a higher percentage of female participants
(65.3%), reflecting the broader epidemiological trend of a higher prevalence of
HIV among women in certain regions. The diverse representation of
ethnicities, religions, and marital statuses ensures a heterogeneous sample,
contributing to the study's generalizability.
The findings of this study indicate that there is a low level of awareness of
telemedicine among patients living with HIV attending AKTH. Only 25.5% of
respondents had heard of telemedicine before the survey, and only 3.6%
were familiar with telemedicine services in Nigeria. This is consistent with
other studies that have found that telemedicine is still relatively unknown in
many parts of the world, particularly in low- and middle-income countries
(LMICs).
44
the low level of awareness, there was a high level of interest in learning more
about telemedicine. Approximately 62.9% of respondents were interested in
learning more about telemedicine, suggesting that there is a potential demand
for these services among patients living with HIV. This is encouraging, as
telemedicine has the potential to improve access to care for patients living
with HIV in LMICs, where there is often a shortage of healthcare providers.3
The study also found that there is a high level of acceptability and willingness
to use teleconsultation services among patients living with HIV. Approximately
55.7% of respondents were willing to use teleconsultation services for their
HIV care, and a further 28.2% were neutral on the issue. This is higher than
the findings of some other studies, which have found that acceptability of
teleconsultation is lower among patients living with HIV. [4, 5] This is also in
line with a study conducted by Germano Vera Cruz et al. in Mozambique; it
was observed that a majority of participants expressed a high willingness to
use tele-consultation public health services for mild illnesses, affordable
prices, and follow-up consultations.45
There are a number of factors that may contribute to the high level of
acceptability of teleconsultation in this study. First, a significant number of
respondents (61.2%) use technology and the internet daily, suggesting that
they are comfortable using these tools for communication. Second, many
respondents (46.7%) reported that they are interested in teleconsultation
because it would be convenient and save them time. Third, many respondents
(31.8%) reported that they are interested in teleconsultation because it would
give them access to specialist care. The study also found that a number of
factors are associated with patients' acceptance and willingness to use
teleconsultation services for HIV care. These factors include age, gender,
ethnicity, marital status, family type, highest level of education, and
occupation. Patients who were younger, female, married, had a higher level of
45
education, and were employed were more likely to be willing to use
teleconsultation services. This is consistent with the findings of other studies,
which have found that these factors are associated with increased use of
technology and telemedicine [6, 7].
The study also identified a number of challenges that may affect the use of
teleconsultation services in HIV care. These challenges include lack of face-
to-face consultation, technical difficulties, privacy and security concerns,
language barriers, and uncertainty about the quality of care. These challenges
are similar to those that have been identified in other studies of telemedicine
in LMICs [8, 9]. It is important to address these challenges to ensure that
teleconsultation is a viable option for patients living with HIV in these settings.
This is in line with a study carried out by Babatunde et al. in 2021 in Nigeria,
where the potential of telemedicine in revitalizing healthcare systems in low
and middle-income countries (LMICs) was noted, along with various
challenges that could potentially exacerbate health inequalities, particularly
based on income, technical difficulties, and language barriers.52
46
importance of physical assessments during face-to-face encounters with
healthcare providers.
47
This study is one of the first to examine the awareness, acceptability, and
willingness to use teleconsultation among patients living with HIV in Nigeria.
The findings suggest that there is a high level of interest in teleconsultation
among these patients, and that teleconsultation has the potential to improve
access to care for patients living with HIV in Nigeria. However, there are a
number of challenges that need to be addressed in order to ensure that
teleconsultation is a viable option for these patients.
CHAPTER 6
6.1 Conclusions
48
In conclusion, the findings of this study not only shed light on the current
challenges and opportunities but also pave the way for a future where
telemedicine becomes an integral part of healthcare delivery, ultimately
improving the lives of individuals living with HIV in the community.
6.2 Recommendations
Given the low level of awareness of telemedicine among patients living with
HIV at AKTH, targeted educational campaigns are imperative. The following
strategies are recommended:
To foster trust and address privacy concerns, the following measures are
recommended:
49
1. Training Programs: Offer training programs to enhance participants'
technical skills, providing step-by-step guidance on accessing and
utilizing tele-consultation platforms.
2. User-Friendly Platforms: Advocate for or develop user-friendly
telemedicine platforms that are intuitive and require minimal technical
expertise.
Infrastructure Improvement:
50
Training Programs: In collaboration with educational institutions, initiate
training programs for healthcare professionals to enhance their skills in
telemedicine, focusing on ethical considerations, patient communication, and
the use of telehealth technologies.
51
Training Programs for Staff: Conduct comprehensive training programs for
healthcare staff to enhance their proficiency in telehealth services. This
includes both clinical and administrative staff to ensure seamless integration.
6.2.5 Community
6.2.6 Individuals
52
REFERENCES;
7. https://unaids.org/sites/default/files/media_asset/UNAIDS
FactSheet_en.pdf Last accessed 7th August 2023
53
8. Federal Ministry of Health, Nigeria. Nigeria HIV/AIDS indicator and
Impact survey (NAIIS) 2018: Technical report. Abuja, Nigeria. October
2019.https://www.naiis.ng/resource/NAIIS-Reprt-2018.pdf last
th
accessed 7 August 2023.
54
16. American Telemedicine Association (ATA)
2001;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221880/
17. Willemain, T.R. and R.G. Mark. Models of remote health care systems.
Biomed Sci Instrutn 8:9, 1971.2
21. World Health Organization. Health topics: Health systems. Available at:
http://who.int Retrieved: (2012).
55
26. Hoffer-Hawlik MA, Moran AE, Burka D, Kaur P, Cai J, Frieden TR, et al.
Leveraging telemedicine for chronic disease management in low- and
middle-income countries during COVID-19. Glob Heart. 15:63., Scott
Kruse C, Karem P, Shifflett K, Vegi L, Ravi K, Brooks M. Evaluating
barriers to adopting telemedicine worldwide: a systematic review. J
Telemed Telecare SAGE Publications. 2018;24:4–12.
27. Tran BX, Hoang MT, Vo LH, Le HT, Nguyen TH, Vu GT, et al.
Telemedicine in the COVID-19 pandemic: motivations for integrated,
interconnected, and community-based health delivery in resource-
scarce settings? Front Psychiatry. 2020;11: 564452.
29) Abolade, T. O., & Durosinmi, A. E. (2018). The Benefits and Challenges of
E-Health Applications in Developing Nations: A Review. 14th ISTEAMS
Multidisciplinary Conference, Vol 14, 37–44.2.
56
32) https://unaids.org/sites/default/files/media_asset/UNAIDS
FactSheet_en.pdf Last accessed 7th August 2023
33) Federal Ministry of Health, Nigeria. Nigeria HIV/AIDS indicator and Impact
survey (NAIIS) 2018: Technical report. Abuja, Nigeria. October
2019.https://www.naiis.ng/resource/NAIIS-Reprt-2018.pdf last accessed 7th
August 2023.
34) León, A., Cáceres, C., Fernández, E., Chausa, P., Martin, M., Codina, C.,
Rousaud, A., Blanch, J., Mallolas, J., Martinez, E., Blanco, J., Laguno, M.,
Larrousse, M., Milinkovic, A., Zamora, L., Canal, N., Miro, J., Gatell, J.,
Gómez, E., & García, F. (2011). A New Multidisciplinary Home Care
Telemedicine System to Monitor Stable Chronic Human Immunodeficiency
Virus-Infected Patients: A Randomized Study. PLoS ONE, 6.
https://doi.org/10.1371/journal.pone.0014515.
35) Kim YN, Shin DG, Park S, Lee CH. Randomized clinical trial to assess the
effectiveness of remote patient monitoring and physician care in reducing
office blood pressure. Hypertens Res. 2015;38(7):491–497. doi:
10.1038/hr.2015.32.
37) Saifu, H., Asch, S., Goetz, M., Smith, J., Graber, C., Schaberg, D., & Sun,
B. (2012). Evaluation of human immunodeficiency virus and hepatitis C
telemedicine clinics.. The American journal of managed care, 18 4, 207-12.
38) Arize, I., & Onwujekwe, O. (2017). Acceptability and willingness to pay for
telemedicine services in Enugu state, southeast Nigeria. Digital health, 3.
https://doi.org/10.1177/2055207617715524.
40) Anderson, K., Francis, T., Ibáñez-Carrasco, F., & Globerman, J. (2017).
Physician’s Perceptions of Telemedicine in HIV Care Provision: A Cross-
57
Sectional Web-Based Survey. JMIR Public Health and Surveillance, 3.
https://doi.org/10.2196/publichealth.6896.
41) Galaviz, K., Shah, S., Gutierrez, M., Collins, L., Lahiri, C., Moran, C.,
Szabo, B., Sumitani, J., Rhodes, J., Marconi, V., Nguyen, M., Lucio, V.,
Armstrong, W., & Colasanti, J. (2021). Patient Experiences with Telemedicine
for HIV Care during the first COVID-19 Wave in Atlanta, Georgia.. AIDS
research and human retroviruses. https://doi.org/10.1089/aid.2021.0109.
43) Kadam, Dileep B.; Salvi, Sonali P.; Rathod, Tara B.1; Chandanwale, Ajay
S.2. Utilizing Telemedicine as a Tool for Management of PLHIV at a Tertiary
Care Institute. Medical Journal of Dr. D.Y. Patil Vidyapeeth ():, June 02, 2023.
| DOI: 10.4103/mjdrdypu.mjdrdypu_826_22
44) Baudier, P., Kondrateva, G., Ammi, C., Chang, V., & Schiavone, F. (2020).
Patients’ perceptions of teleconsultation during COVID-19: A cross-national
study. Technological Forecasting and Social Change, 163, 120510 - 120510.
https://doi.org/10.1016/j.techfore.2020.120510.
46) Saragih, I., Tonapa, S., Osingada, C., Porta, C., & Lee, B. (2021). Effects
of telehealth-assisted interventions among people living with HIV/AIDS: A
systematic review and meta-analysis of randomized controlled studies..
Journal of telemedicine and telecare, 1357633X211070726.
https://doi.org/10.1177/1357633X211070726.
47) Baudier, P., Kondrateva, G., Ammi, C., Chang, V., & Schiavone, F. (2020).
Patients’ perceptions of teleconsultation during COVID-19: A cross-national
study. Technological Forecasting and Social Change, 163, 120510 - 120510.
https://doi.org/10.1016/j.techfore.2020.120510.
58
Surveill.2017 may 30;3(2);e31. Doi
49) Waldura, J., Neff, S., & Goldschmidt, R. (2011). Teleconsultation for
clinicians who provide human immunodeficiency virus care: experience of the
national HIV telephone consultation service.. Telemedicine journal and e-
health : the official journal of the American Telemedicine Association, 17 6,
472-7. https://doi.org/10.1089/tmj.2010.0210.
57) Centers for Disease Control and Prevention. Division for heart disease
and stroke prevention: telehealth interventions to improve chronic disease.
59
Available from: https://www.cdc.gov/dhdsp/pubs/telehealth.htm. Accessed 13
May 2022
60) Iliyasu Z, Hassan-Hanga F, Ajuji SI, Bello MM, Abdulkadir SS, Nass NS,
Salihu HM, Aliyu MH. Correlates of Health Care Workers' Knowledge and HIV-
Exposed Infant Immunization Counseling Practice in Northern Nigeria. Int J
MCH AIDS. 2021;10(1):55-65. doi: 10.21106/ijma.432. Epub 2020 Dec 30.
PMID: 33442492; PMCID: PMC7792747.
61/38) Arize, I., & Onwujekwe, O. (2017). Acceptability and willingness to pay
for telemedicine services in Enugu state, southeast Nigeria. Digital health, 3.
https://doi.org/10.1177/2055207617715524
60
Dear respondent,
2.
How old are you? _______________________________years old
7.
Total Number of children ……………………….
61
[ 2 ] Polygamous
General health
62
Section 2: Awareness of Telemedicine
……………………………………………………………………………………..
21. If no, would you be interested in learning more about
telemedicine services for HIV care in Nigeria?
( ) Yes
( ) No
( ) Not Sure
22. Which sources of information about telemedicine do you trust the
most?
( ) Healthcare Providers
( ) Government Health Agencies
( ) Non-Governmental Organizations (NGOs)
( ) Media (TV/Radio/Newspaper/Internet)
( ) Friends/Family
( ) Other (Specify): ……………………………………..
23. Would you be willing to use tele-consultation services for your HIV
care?
( ) Yes
( ) No
63
( ) Not Sure
24. If no or not sure, what are the reasons? (Multiple responses
allowed)
( ) Lack of Trust in Technology
( ) Concerns about Privacy and Security
( ) Lack of Technical Skills
( ) Prefer In-Person Consultations
( ) Fear of Misdiagnosis or Inaccurate Treatment
( ) Lack of Information about Tele-consultation Services
( ) Other (Specify):
…………………………………………………….
25. If yes, what factors would motivate you to use tele-consultation
services for HIV care? (Multiple responses allowed)
( ) Convenience and Time-Saving
( ) Reduced Travel Costs
( ) Access to Specialists
( ) Availability of Remote Monitoring
( ) Assurance of Confidentiality in Tele-consultations
( ) Positive Reviews or Recommendations from Others
( ) Other (Specify):
…………………………………………………………….
26. Do you have any concerns or fears about using tele-consultation
services for your HIV care?
( ) Yes
( ) No
27. Are there any specific features or services you would like to see in
a tele-consultation platform for HIV care?
64
( ) Language barriers
( ) Uncertainty about the quality of care
( ) Other (Specify):
………………………………………………………………..
( ) Yes
( ) No
31. If you answered "Yes," please explain why you would give a positive
qualified score to tele-consultation. (Open-ended)
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………
32. If you answered "No," please explain why you would not give a positive
qualified score to tele-consultation. (Open-ended)
…………………………………………………………………………………………
…………………………………………………………………………………………
………………………
( ) Very Acceptable
( ) Acceptable
( ) Neutral
( ) Unacceptable
( ) Very Unacceptable
65
…………………………………………………………………………………………
………………………
Thank you for your participation in this survey. Your valuable insights will
contribute to our understanding of the awareness and acceptability of
telemedicine and tele-consultation for patients living with HIV.
INTRODUCTION
Benefits to yourself:
By agreeing to take part in this study, you will provide information together
with other participants regarding telemedicine and tele-consultation
66
acceptability among HIV-positive patients attending Aminu Kano Teaching
Hospital, which will inform communication strategies and health education to
improve HIV care services in the facility.
Benefits for the community This study will help with valuable insights that
can inform healthcare policies and strategies leading to integration of tele-
consultation into HIV care in a patient-centered manner, it will also enhanced
access, patients engagement, resource optimization, treatment adherence,
stigma reduction, provider training, health system efficiency and literature
contribution..
Confidentiality
Your name and identity will not be collected. The data and reports from this
project will not have anything to identify you. All information will be kept
confidential.
Voluntary consent
Your participation in this study is voluntary. You do not have to take part in
this study if you do not wish to do so. You may decline participation now or
later. If you refuse to participate, there will be no consequences.
Contact information
You can ask any questions about this study or the consent form now. If you
have any concerns or questions subsequently, please contact this number
07061624466, 08177720933 or contact my supervisor Prof. Zubairu Iliyasu
on +2348035868293 or chairman Ethics committee Aminu Kano Teaching
Hospital Kano, Prof Musa M. Borodo on +2348033268903.
67
CERTIFICATE OF CONSENT
- I further understand that my records will be kept confidential and that I may withdraw
- I understand the benefits and risks of the study. If I have concerns, about
my participation in the study, I can contact the student, the principal
investigator or Chairman of the ethics committee at any time.
- I have been informed orally and in writing of whom to contact in case of an
emergency. I agree to participate in this study as a volunteer subject
- I consent voluntarily to be a participant in this study and understand that I
have the right to withdraw from the study at any time, without any
consequences to me.
Date ……………………………………………………….
68
“I, the undersigned, have explained to the participant in a language he/she
understands the procedures to be followed in the study and the risks and
benefits involved."
__________ ____________________________
Date Signature of Investigator
__________ _____________________________
Date Signature of Witness to the Above Signatures and Explanations
69